cometadata/datacite-titles-descriptions-related-identifiers huggingface dataset:
DOI: 10.6084/m9.figshare.17091209
title: Supplementary Material for: Developing a Stroke Risk Prediction Model Using Cardiovascular Risk Factors: The Suita Study

description: <b><i>Introduction:</i></b> Stroke remains a major cause of death and disability in Japan and worldwide. Detecting individuals at high risk for stroke to apply preventive approaches is recommended. This study aimed to develop a stroke risk prediction model among urban Japanese using cardiovascular risk factors. <b><i>Methods:</i></b> We followed 6,641 participants aged 30–79 years with neither a history of stroke nor coronary heart disease. The Cox proportional hazard model estimated the risk of stroke incidence adjusted for potential confounders at the baseline survey. The model’s performance was assessed using the receiver operating characteristic curve and the Hosmer-Lemeshow statistics. The internal validity of the risk model was tested using derivation and validation samples. Regression coefficients were used for score calculation. <b><i>Results:</i></b> During a median follow-up duration of 17.1 years, 372 participants developed stroke. A risk model including older age, current smoking, increased blood pressure, impaired fasting blood glucose and diabetes, chronic kidney disease, and atrial fibrillation predicted stroke incidence with an area under the curve = 0.76 and <i>p</i> value of the goodness of fit = 0.21. This risk model was shown to be internally valid (<i>p</i> value of the goodness of fit in the validation sample = 0.64). On a risk score from 0 to 26, the incidence of stroke for the categories 0–5, 6–7, 8–9, 10–11, 12–13, 14–15, and 16–26 was 1.1%, 2.1%, 5.4%, 8.2%, 9.0%, 13.5%, and 18.6%, respectively. <b><i>Conclusion:</i></b> We developed a new stroke risk model for the urban general population in Japan. Further research to determine the clinical practicality of this model is required.
DOI: 10.6084/m9.figshare.17091182
title: NPR3_supp tables 1-3.docx

description: Supplemental tables 1-3.
DOI: 10.6084/m9.figshare.17091182.v2
title: NPR3_supp tables 1-3.docx

description: Supplemental tables 1-3.
DOI: 10.6084/m9.figshare.17091182.v1
title: NPR3_supp tables 1-3.docx

description: Supplemental tables 1-3.
DOI: 10.17028/rd.lboro.17091212.v1
title: Supplementary information files for Management of fatigue with physical activity and behavioural change support in vasculitis: a feasibility study

description: OBJECTIVE: Patients with ANCA-associated vasculitis (AAV) experience high levels of fatigue, despite disease remission. This study assessed the feasibility and acceptability of a definitive randomized controlled trial of a behavioural-based physical activity intervention to support fatigue self-management in AAV patients. METHODS: AAV patients in disease remission with fatigue (Multidimensional Fatigue Inventory-20 general fatigue domain ≥14) were randomly allocated to intervention or standard care in this single-centre open-label randomized controlled feasibility study. The intervention lasted 12 weeks and comprised eight face-to-face physical activity sessions with a facilitator and 12 weekly telephone calls. Participants were encouraged to monitor their physical activity using a tracker device (Fitbit). Standard care involved sign-posting to fatigue websites. The primary outcome was feasibility of a phase III trial assessed against three stop/go traffic light criteria, (recruitment, intervention adherence and study withdrawal). A qualitative study assessed participant views about the intervention. RESULTS: A total of 248 patients were screened and 134 were eligible to participate (54%). Stop/go criteria were amber for recruitment; 43/134 (32%, 95% CI: 24, 40) eligible participants randomized, amber for adherence; 73% of participants attended all eight physical activity sessions, but only 11/22 (50%, 95% CI: 29, 71%) completed the intervention as per the intended schedule, and green for study withdrawal; 2/43 participants withdrew before 24 weeks (5%, 95% CI: 0, 11). Qualitative results suggested the intervention was acceptable. CONCLUSION: This study suggests a behavioural-based physical activity intervention targeting fatigue self-management was acceptable to patients with AAV, although recruitment and protocol adherence will need modification prior to a definitive trial. CLINICAL TRIAL REGISTRATION NUMBER: ISRCTN11929227.
DOI: 10.17028/rd.lboro.17091212
title: Supplementary information files for Management of fatigue with physical activity and behavioural change support in vasculitis: a feasibility study

description: OBJECTIVE: Patients with ANCA-associated vasculitis (AAV) experience high levels of fatigue, despite disease remission. This study assessed the feasibility and acceptability of a definitive randomized controlled trial of a behavioural-based physical activity intervention to support fatigue self-management in AAV patients. METHODS: AAV patients in disease remission with fatigue (Multidimensional Fatigue Inventory-20 general fatigue domain ≥14) were randomly allocated to intervention or standard care in this single-centre open-label randomized controlled feasibility study. The intervention lasted 12 weeks and comprised eight face-to-face physical activity sessions with a facilitator and 12 weekly telephone calls. Participants were encouraged to monitor their physical activity using a tracker device (Fitbit). Standard care involved sign-posting to fatigue websites. The primary outcome was feasibility of a phase III trial assessed against three stop/go traffic light criteria, (recruitment, intervention adherence and study withdrawal). A qualitative study assessed participant views about the intervention. RESULTS: A total of 248 patients were screened and 134 were eligible to participate (54%). Stop/go criteria were amber for recruitment; 43/134 (32%, 95% CI: 24, 40) eligible participants randomized, amber for adherence; 73% of participants attended all eight physical activity sessions, but only 11/22 (50%, 95% CI: 29, 71%) completed the intervention as per the intended schedule, and green for study withdrawal; 2/43 participants withdrew before 24 weeks (5%, 95% CI: 0, 11). Qualitative results suggested the intervention was acceptable. CONCLUSION: This study suggests a behavioural-based physical activity intervention targeting fatigue self-management was acceptable to patients with AAV, although recruitment and protocol adherence will need modification prior to a definitive trial. CLINICAL TRIAL REGISTRATION NUMBER: ISRCTN11929227.
DOI: 10.5281/zenodo.5734313
title: Presence of skin α-synuclein deposits discriminates Parkinson's disease from progressive supranuclear palsy and corticobasal syndrome

description: Dataset
DOI: 10.5281/zenodo.5734312
title: Presence of skin α-synuclein deposits discriminates Parkinson's disease from progressive supranuclear palsy and corticobasal syndrome

description: Dataset
DOI: 10.5522/04/17086559
title: Data to reproduce the figures from the paper "On the impact of launch power optimisation and transceiver noise on the performance of ultra-wideband transmission systems"

description: This data provides the data points of Figures 3-11 from the the paper "On the impact of launch power optimisation and transceiver noise on the performance of ultra-wideband transmission systems", submitted in the Journal of Optical Communications and Networking (JOCN).<br>Each figure are in separate folders. For each figure you will find the corresponding TXT file used to plot the data of the figures in the paper. The TXT files is made of columns, where each column represent one of the curves in the graphs. The titles of each columns are self explanatory so you can easily related the columns with the graphs in the paper.Please, read the file "read me" if you find it in the relevant figure folder.
DOI: 10.5522/04/17086559.v1
title: Data to reproduce the figures from the paper "On the impact of launch power optimisation and transceiver noise on the performance of ultra-wideband transmission systems"

description: This data provides the data points of Figures 3-11 from the the paper "On the impact of launch power optimisation and transceiver noise on the performance of ultra-wideband transmission systems", submitted in the Journal of Optical Communications and Networking (JOCN).<br>Each figure are in separate folders. For each figure you will find the corresponding TXT file used to plot the data of the figures in the paper. The TXT files is made of columns, where each column represent one of the curves in the graphs. The titles of each columns are self explanatory so you can easily related the columns with the graphs in the paper.Please, read the file "read me" if you find it in the relevant figure folder.
DOI: 10.6084/m9.figshare.12323366
title: Viral sequences

description: Alarcon-Schumacher et al 2021, <i>msystems</i>Supplementary material
DOI: 10.6084/m9.figshare.12323366.v1
title: Viral sequences

description: Alarcon-Schumacher et al 2021, <i>msystems</i>Supplementary material
DOI: 10.6084/m9.figshare.17091293
title: Assembly FASTA Files

description: FASTA sequences of Pilot HATUA isolates from Kenya and Uganda.
DOI: 10.6084/m9.figshare.14102438
title: Virus- host_prediction

description: Virus-Host pairing
DOI: 10.6084/m9.figshare.14102438.v2
title: Virus- host_prediction

description: Virus-Host pairing
DOI: 10.6084/m9.figshare.14102438.v1
title: Virus- host_prediction

description: Virus-Host pairing
DOI: 10.6084/m9.figshare.16553199
title: SARS-CoV-2 variants of concern dominate in Lahore, Pakistan in April 2021

description: Supplementary Material for 'SARS-CoV-2 variants of concern dominate in Lahore, Pakistan in April 2021'
DOI: 10.6084/m9.figshare.16553199.v1
title: SARS-CoV-2 variants of concern dominate in Lahore, Pakistan in April 2021

description: Supplementary Material for 'SARS-CoV-2 variants of concern dominate in Lahore, Pakistan in April 2021'
DOI: 10.5281/zenodo.5734340
title: OK Aura Wake-up Word Dataset

description: Speech dataset for wake-up word (WuW) detection in Telefónica's home assistant, Aura. It contains 1247 utterances (1.4 hours) from ~80 speakers. Speakers pronounce the wake-up word itself "OK Aura", plus other sentences that might be similar, or not, to "OK Aura". This dataset contains rich metadata annotations, so it is possible to study diverse factors and biases that might affect wake-up word detection performance: accent, gender, prosody/emotion, room size, distance to the microphone, etc. Besides, it also contains recordings of sentences that are phonetically similar to "OK Aura", like "Porque Laura..." or "... como Aura...", with the purpose to experiment with difficult sentences.
DOI: 10.5281/zenodo.5734339
title: OK Aura Wake-up Word Dataset

description: Speech dataset for wake-up word (WuW) detection in Telefónica's home assistant, Aura. It contains 1247 utterances (1.4 hours) from ~80 speakers. Speakers pronounce the wake-up word itself "OK Aura", plus other sentences that might be similar, or not, to "OK Aura". This dataset contains rich metadata annotations, so it is possible to study diverse factors and biases that might affect wake-up word detection performance: accent, gender, prosody/emotion, room size, distance to the microphone, etc. Besides, it also contains recordings of sentences that are phonetically similar to "OK Aura", like "Porque Laura..." or "... como Aura...", with the purpose to experiment with difficult sentences.
DOI: 10.25502/029y-pk18/d
title: Farmer perception on culinary quality of improved plantain genotypes in the communities surrounding Mount Cameroon National park

description: The overall objective of the project was to transfer and promote improved plantain production technologies to enhance and profitability of plantain production in PSMNR target villages around the MCNP, thereby improving the livelihood of involved farmers. A planning. The experiments were set up to evaluate in participatory manner the performance of cosmolure trap against banana weevils in the demonstration plots planted with improved varieties of plantain from IITA and FHIA.
DOI: 10.6084/m9.figshare.17091368.v1
title: Data for "Contrasting mobility of bioavailable arsenic and antimony in estuarine mangrove sediments: Insight from seasonal change and bioturbation"

description: Data used in the article: "Contrasting mobility of bioavailable arsenic and antimony in estuarine mangrove sediments: Insight from seasonal change and bioturbation"
DOI: 10.6084/m9.figshare.17091368
title: Data for "Contrasting mobility of bioavailable arsenic and antimony in estuarine mangrove sediments: Insight from seasonal change and bioturbation"

description: Data used in the article: "Contrasting mobility of bioavailable arsenic and antimony in estuarine mangrove sediments: Insight from seasonal change and bioturbation"
DOI: 10.5281/zenodo.5734317
title: PEMA databases

description: In this repo, the CREST and the RDPTClassifier oriented databases unsed in PEMA will be versioned.
DOI: 10.6084/m9.figshare.13109813
title: Characterizing measures for the assessment of cluster analysis and community detection

description: The materials of this dataset are used in: <br>- N. Arınık, V. Labatut and R. Figueiredo, "Characterizing measures for the assessment of cluster analysis and community detection", Modèles & Analyse des Réseaux : Approches Mathématiques & Informatiques (MARAMI), 2020, url: https://hal.archives-ouvertes.fr/hal-02993542/<br>- N. Arınık, V. Labatut and R. Figueiredo, "<em>Characterizing and Comparing External Measures for the Assessment of Cluster Analysis and Community Detection</em>", in <em>IEEE Access</em>, vol. 9, pp. 20255-20276, 2021, doi:https://doi.org/10.1109/ACCESS.2021.3054621.<br>This dataset contains:* `<i>figs.zip</i>` which contains the plot files<br>* `<i>data&results.zip</i>` which contains the necessary data to perform our analysis, as well as result files<br>
DOI: 10.6084/m9.figshare.13109813.v1
title: Characterizing measures for the assessment of cluster analysis and community detection

description: The materials of this dataset are used in the following conference: Modèles & Analyse des Réseaux : Approches Mathématiques & Informatiques (MARAMI), 2020<br><br>This dataset contains:* `<i>figures.zip</i>` which contains the plot files<br>* `<i>data.zip</i>` which contains the necessary data to perform our analysis<br>
DOI: 10.7303/syn26483904
title: Malaria cases in Brazil
DOI: 10.6084/m9.figshare.17091401
title: Table 4. Thermodynamic Parameters

description: Thermodynamic data for suggarcane Baggase-Lignin, Suggarcane Baggase-Lignin Carbon and Amination Lignin Suggarcane<br>
DOI: 10.6084/m9.figshare.17091401.v1
title: Table 4. Thermodynamic Parameters

description: Thermodynamic data for suggarcane Baggase-Lignin, Suggarcane Baggase-Lignin Carbon and Amination Lignin Suggarcane<br>
DOI: 10.5281/zenodo.5733926
title: Image Dataset-Drone-AI4Agriculture

description: Dataset containing multispectral drone imagery from 3 Ribera de Duero vineyards This dataset comprises imagery from three vineyards in Ribera de Duero region, obtained with a multispectral sensor attached to a drone. Contents: • NIR, Red, Red-Edge, Green bands • NDVI Index
DOI: 10.5281/zenodo.5733925
title: Image Dataset-Drone-AI4Agriculture

description: Dataset containing multispectral drone imagery from 3 Ribera de Duero vineyards This dataset comprises imagery from three vineyards in Ribera de Duero region, obtained with a multispectral sensor attached to a drone. Contents: • NIR, Red, Red-Edge, Green bands • NDVI Index
DOI: 10.25402/cer.17091413
title: Supplementary Tables: Supplementary Materials. The cost-effectiveness of oral semaglutide versus empagliflozin in Type 2 diabetes in Denmark

description: Table S1: Baseline Characteristics.Table S2: Treatment Effects – First Line.Table S3: Adverse Events.Table S4: Treatment effects for second/third line treatments (treatment policy estimand).Table S5: Proportion of patients on preventive medication.Table S6: Screening and patient management proportions.Table S7: Sensitivity and specificity of tests.Table S8 Annual treatment costs applied (DKK, AIP 2020, [20]).Table S9 Cost Inputs for the CDM (Costs inflated to 2020 values, DKK).Table S10: Utilities used in CDM.Table S11: Scenario analysis results.Table S12: Breakdown of costs (DKK, per average patient).<br>
DOI: 10.25402/cer.17091413.v1
title: Supplementary Tables: Supplementary Materials. The cost-effectiveness of oral semaglutide versus empagliflozin in Type 2 diabetes in Denmark

description: Table S1: Baseline Characteristics.Table S2: Treatment Effects – First Line.Table S3: Adverse Events.Table S4: Treatment effects for second/third line treatments (treatment policy estimand).Table S5: Proportion of patients on preventive medication.Table S6: Screening and patient management proportions.Table S7: Sensitivity and specificity of tests.Table S8 Annual treatment costs applied (DKK, AIP 2020, [20]).Table S9 Cost Inputs for the CDM (Costs inflated to 2020 values, DKK).Table S10: Utilities used in CDM.Table S11: Scenario analysis results.Table S12: Breakdown of costs (DKK, per average patient).<br>
DOI: 10.25402/epi.17091419
title: Supplementary Tables – Sex- and tissue- specific effects of binge levels of prenatal alcohol consumption on DNA methylation at birth

description: <b>Supplementary Table 1. </b>List of top 1000 limma-ranked probes in buccal of (a) male and (b) female offspring<b></b> <b>Supplementary Table 2. </b>List of top 1000 limma-ranked probes in placenta of (a) male and (b) female offspring
DOI: 10.25402/epi.17091419.v1
title: Supplementary Tables – Sex- and tissue- specific effects of binge levels of prenatal alcohol consumption on DNA methylation at birth

description: <b>Supplementary Table 1. </b>List of top 1000 limma-ranked probes in buccal of (a) male and (b) female offspring<b></b> <b>Supplementary Table 2. </b>List of top 1000 limma-ranked probes in placenta of (a) male and (b) female offspring
DOI: 10.6084/m9.figshare.17091374
title: Correlation networks for CYLD from Immuno-Navigator

description: This is a Cytoscape file containing the correlation networks of CYLD from human mature B cells, pre-B cells and Chronic Lymphocytic Leukemia cells that were mined from the Immuno-Navigator database.
DOI: 10.6084/m9.figshare.17091374.v1
title: Correlation networks for CYLD from Immuno-Navigator

description: This is a Cytoscape file containing the correlation networks of CYLD from human mature B cells, pre-B cells and Chronic Lymphocytic Leukemia cells that were mined from the Immuno-Navigator database.
DOI: 10.25345/c5rz9d
title: MassIVE MSV000088464 - GNPS_GARDP_2021project_BS_2021_Mxf233_B10_PC6
title: This is the raw data for the analysis Myxococcus fulvus 233 which show activity.
DOI: 10.5281/zenodo.13791
title: MD simulation trajectory and related files for POPC bilayer (GAFFlipid, Gromacs 4.5)

description: Equilibrated POPC lipid bilayer simulation ran with Gromacs 4.5, GAFFlipid force field (http://dx.doi.org/10.1039/C2SM26007G), 30ns, T=303K, 126 POPC molecules, 3948 water molecules. This data is ran for the nmrlipids.blospot.fi project. More details from nmrlipids.blospot.fi and https://github.com/NMRLipids/nmrlipids.blogspot.fi. If data is used, please cite nmrlipids.blogspot.fi project and the original publication of the parameters: Dickson et al. Soft Matter, 2012,8, 9617-9627 http://dx.doi.org/10.1039/C2SM26007G.
description: {"references": ["nmrlipids.blogspot.fi", "Dickson et al. Soft Matter, 2012,8, 9617-9627 http://dx.doi.org/10.1039/C2SM26007G"]}
DOI: 10.5281/zenodo.5734055
title: msd-errors - Data for scaling figures

description: Data for a figure that shows the scaling of uncertainty as a function of simulation length and number of atoms and step size, for both true and anitcorrelated random walks. This compares the kinisi approach (on just 32 unique walks) with the numerical values from (1024 unique walks). <br><br>Created using showyourwork from this GitHub repo.
DOI: 10.6084/m9.figshare.16832404
title: Supplementary Material for: Variable Clinical Presentation of Children with Hereditary Hypophosphatemic Rickets with Hypercalciuria: A Case Series and Review of the Literature

description: Introduction: Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH) is a rare condition of renal phosphate wasting due to SLC34A3 mutations [1]. Patients exhibit low serum phosphorus, high 1,25-dihydroxyvitamin D and inappropriately high urine phosphate and calcium. However, symptoms vary and little is known about specific phenotype-genotype correlations. Methods: We report three HHRH cases in unrelated 12-year-old, 9-year-old and 14-year-old patients and perform a systematic literature review. Results: All three patients exhibited labs typical of HHRH. Yet, their presentations differed and 2 novel SLC34A3 variants were identified. As found in the literature review, bone symptoms are most common (50%), followed by renal symptoms (17%), combined bone and renal symptoms (18%) and asymptomatic (9%). Conclusion: These three cases highlight the variability of presenting signs and symptoms among individuals with HHRH. An accurate diagnosis is critical, as treatment differs from other disorders of phosphate wasting, urinary stones, and mineralization defects.
DOI: 10.6084/m9.figshare.16832404.v1
title: Supplementary Material for: Variable Clinical Presentation of Children with Hereditary Hypophosphatemic Rickets with Hypercalciuria: A Case Series and Review of the Literature

description: Introduction: Hereditary Hypophosphatemic Rickets with Hypercalciuria (HHRH) is a rare condition of renal phosphate wasting due to SLC34A3 mutations [1]. Patients exhibit low serum phosphorus, high 1,25-dihydroxyvitamin D and inappropriately high urine phosphate and calcium. However, symptoms vary and little is known about specific phenotype-genotype correlations. Methods: We report three HHRH cases in unrelated 12-year-old, 9-year-old and 14-year-old patients and perform a systematic literature review. Results: All three patients exhibited labs typical of HHRH. Yet, their presentations differed and 2 novel SLC34A3 variants were identified. As found in the literature review, bone symptoms are most common (50%), followed by renal symptoms (17%), combined bone and renal symptoms (18%) and asymptomatic (9%). Conclusion: These three cases highlight the variability of presenting signs and symptoms among individuals with HHRH. An accurate diagnosis is critical, as treatment differs from other disorders of phosphate wasting, urinary stones, and mineralization defects.
DOI: 10.6084/m9.figshare.17086406
title: Pyrosequencing data for epigenetic age estimation

description: The initial data used for the analysis <b>"Evaluation of epigenetic age based on DNA methylation analysis of several CpG sites in Ukrainian population"</b> are presented here. <br><b>"Pyrosequencing data summary.xlsx"</b> is a document, which contains the summarized data used in the article. In the "Data_final" sheet CpG values taken for the analysis can be found. The "Raw_data_location" sheet contains the name (presented as a number) of the corresponding ".pyrorun" file (can be found in the <b>"Pyrosequencing_files.zip"</b>) and CpG report file for each of the samples taken for the study (can be found in the <b>"Reports.zip"</b>). Only samples, that were used for the study are included in the report files.<br>
DOI: 10.6084/m9.figshare.17086406.v1
title: Pyrosequencing data for epigenetic age estimation

description: The initial data used for the analysis <b>"Evaluation of epigenetic age based on DNA methylation analysis of several CpG sites in Ukrainian population"</b> are presented here. <br><b>"Pyrosequencing data summary.xlsx"</b> is a document, which contains the summarized data used in the article. In the "Data_final" sheet CpG values taken for the analysis can be found. The "Raw_data_location" sheet contains the name (presented as a number) of the corresponding ".pyrorun" file (can be found in the <b>"Pyrosequencing_files.zip"</b>) and CpG report file for each of the samples taken for the study (can be found in the <b>"Reports.zip"</b>). Only samples, that were used for the study are included in the report files.<br>